DSM-Firmenich AG

Amsterdam Stock Exchange DSFIR.AS

DSM-Firmenich AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -905.08 M

DSM-Firmenich AG Net Cash Used Provided By Financing Activities is USD -905.08 M for the year ending December 31, 2023, a -41.46% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • DSM-Firmenich AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -639.82 M, a 42.88% change year over year.
  • DSM-Firmenich AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -1.12 B, a -1,204.78% change year over year.
  • DSM-Firmenich AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 101.39 M, a 106.78% change year over year.
  • DSM-Firmenich AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -1.49 B, a -225.71% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
Amsterdam Stock Exchange: DSFIR.AS

DSM-Firmenich AG

CEO Mr. Dimitri de Vreeze
IPO Date April 18, 2023
Location Switzerland
Headquarters Wurmisweg 576
Employees 27,926
Sector Health Care
Industries
Description

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

StockViz Staff

January 15, 2025

Any question? Send us an email